Japan · Delayed Price · Currency is JPY Alfresa Holdings Company Description
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.
It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses.
In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products.
The company was incorporated in 2003 and is based in Tokyo, Japan.
| Country | Japan |
| Founded | 2003 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 12,452 |
| CEO | Ryuji Arakawa |
Contact Details
Address: Ote Center Building Tokyo, 100-0004 Japan | |
| Phone | 81 3 5219 5100 |
| Website | alfresa.com |
Stock Details
| Ticker Symbol | 2784 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3126340003 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Ryuji Arakawa | Chief Executive Officer |